{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T15:52:20Z","timestamp":1792857140858,"version":"4.5.0"},"reference-count":28,"publisher":"Society of Nuclear Medicine","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.2967\/jnumed.116.185140","type":"journal-article","created":{"date-parts":[[2017,3,3]],"date-time":"2017-03-03T01:25:30Z","timestamp":1488504330000},"page":"936-941","source":"Crossref","is-referenced-by-count":57,"title":["Proof of Therapeutic Efficacy of a<sup>177<\/sup>Lu-Labeled Neurotensin Receptor 1 Antagonist in a Colon Carcinoma Xenograft Model"],"prefix":"10.2967","volume":"58","author":[{"given":"J\u00f6rg","family":"Schulz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Rohracker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marvin","family":"Stiebler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Goldschmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"St\u00f6ber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Noriega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette","family":"Pethe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Lukas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Osterkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Reineke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aileen","family":"H\u00f6hne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Smerling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Amthauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2017,3,2]]},"reference":[{"key":"2021051712104375000_58.6.936.1","doi-asserted-by":"publisher","DOI":"10.1007\/s002590050034"},{"key":"2021051712104375000_58.6.936.2","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1530\/EJE-14-0354","article-title":"GEP-NETs update: biotherapy for neuroendocrine tumours","volume":"172","author":"Alonso-Gordoa","year":"2015","journal-title":"Eur J Endocrinol."},{"key":"2021051712104375000_58.6.936.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-6147(99)01357-7"},{"key":"2021051712104375000_58.6.936.4","unstructured":"Johnson LR . Physiology of the Gastrointestinal Tract, Two Volume Set. Burlington, MA: Elsevier Science; 2012."},{"key":"2021051712104375000_58.6.936.5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0004223"},{"issue":"7A","key":"2021051712104375000_58.6.936.6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4236\/jct.2013.47A003","article-title":"Neurotensin receptor 1 (NTSR1) overexpression in breast carcinomas is common and independent of ER\/PR\/Her2 expression","volume":"4","author":"Gui","year":"2013","journal-title":"J Cancer Ther."},{"key":"2021051712104375000_58.6.936.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2008.04.014"},{"key":"2021051712104375000_58.6.936.8","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-015-0094-2"},{"key":"2021051712104375000_58.6.936.9","doi-asserted-by":"publisher","DOI":"10.1136\/gut.42.4.546"},{"key":"2021051712104375000_58.6.936.10","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19990719)82:2<213::AID-IJC11>3.0.CO;2-8"},{"key":"2021051712104375000_58.6.936.11","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-003-1184-3"},{"key":"2021051712104375000_58.6.936.12","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.116.177733"},{"key":"2021051712104375000_58.6.936.13","doi-asserted-by":"publisher","DOI":"10.1089\/cbr.2014.1741"},{"key":"2021051712104375000_58.6.936.14","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.111.088922"},{"key":"2021051712104375000_58.6.936.15","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.107.045054"},{"key":"2021051712104375000_58.6.936.16","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(95)02122-1"},{"key":"2021051712104375000_58.6.936.17","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-008-0894-y"},{"key":"2021051712104375000_58.6.936.18","doi-asserted-by":"publisher","DOI":"10.3390\/ph7040464"},{"key":"2021051712104375000_58.6.936.19","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.1.65"},{"key":"2021051712104375000_58.6.936.20","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/S0022-3565(24)36482-1","article-title":"Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist","volume":"280","author":"Gully","year":"1997","journal-title":"J Pharmacol Exp Ther."},{"key":"2021051712104375000_58.6.936.21","unstructured":"Osterkamp F Smerling C Reineke U Haase C Ungewiss J , inventors; 3BP Pharmaceuticals GmbH, assignee. Neurotensin receptor ligands. European patent application EP20120008208. December 7, 2012."},{"key":"2021051712104375000_58.6.936.22","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.170530"},{"key":"2021051712104375000_58.6.936.23","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(93)81509-X"},{"key":"2021051712104375000_58.6.936.24","first-page":"1023","article-title":"OLINDA\/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine","volume":"46","author":"Stabin","year":"2005","journal-title":"J Nucl Med."},{"key":"2021051712104375000_58.6.936.25","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-0450"},{"key":"2021051712104375000_58.6.936.26","doi-asserted-by":"publisher","DOI":"10.1667\/RR3105"},{"key":"2021051712104375000_58.6.936.27","first-page":"83S","article-title":"Long-term follow-up of renal function after peptide receptor radiation therapy with 90Y-DOTA(0),Tyr(3)-octreotide and 177Lu-DOTA(0), Tyr(3)-octreotate","volume":"46","author":"Valkema","year":"2005","journal-title":"J Nucl Med."},{"key":"2021051712104375000_58.6.936.28","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-006-0232-1"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.116.185140","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T23:37:36Z","timestamp":1750030656000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.116.185140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,2]]},"references-count":28,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,6,1]]},"published-print":{"date-parts":[[2017,6]]}},"alternative-id":["10.2967\/jnumed.116.185140"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.116.185140","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,2]]}}}